{"DataElement":{"publicId":"6571022","version":"1","preferredName":"Chemotherapy Unplanned Dose Reduction Or Therapeutic Procedure Delay Category","preferredDefinition":"The indicated reason for which there was an unplanned dose reduction or unplanned treatment delay","longName":"UNPLN_DSRDT_TXDLY_CAT","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"6564925","version":"1","preferredName":"Chemotherapy Dose Reduced Or Treatment Delay Period Reporting","preferredDefinition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases._An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._Time during which some action is awaited; inactivity resulting in something being put off until a later time; the state of being slower or later._An interval of time._The act of providing a short account.","longName":"2404910v1.0:6564923v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2404910","version":"1","preferredName":"Chemotherapy","preferredDefinition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.  Although this term may be used to describe any therapy involving the use of chemical-based agents, it is most commonly used to refer to the variety of chemical-based agents employed to treat cancer.  Cancer chemotherapy works by arresting or killing the growth and spread of cancer cells.  Because cancer cells usually divide much faster than normal cells, they are often very sensitive to the inhibitory actions of chemotherapeutic agents.  Chemotherapy may also include agents that enhance immune function or alter hormonal activity. (NCI04)","longName":"C15632","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chemotherapy","conceptCode":"C15632","definition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0094ACAF-12DD-1BCA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-09-13","modifiedBy":"ONEDATA","dateModified":"2005-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6564923","version":"1","preferredName":"Dose Reduced Or Therapeutic Procedure Delay Reporting Period","preferredDefinition":"An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount.:An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.:An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.:Time during which some action is awaited; inactivity resulting in something being put off until a later time; the state of being slower or later.:The act of providing a short account.:An interval of time.","longName":"6564923v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dose Reduced","conceptCode":"C49505","definition":"An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Delay","conceptCode":"C25476","definition":"Time during which some action is awaited; inactivity resulting in something being put off until a later time; the state of being slower or later.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Reporting","conceptCode":"C25651","definition":"The act of providing a short account.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Period","conceptCode":"C25616","definition":"An interval of time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B31C82D-6A5C-4483-E053-F662850AB859","latestVersionIndicator":"Yes","beginDate":"2018-11-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2018-11-21","modifiedBy":"ONEDATA","dateModified":"2018-11-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B31C82D-6A6D-4483-E053-F662850AB859","latestVersionIndicator":"Yes","beginDate":"2018-11-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2018-11-21","modifiedBy":"COBARRUBIAK","dateModified":"2018-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6571013","version":"1","preferredName":"Unplanned Dose Reduction Or Therapeutic Procedure Delay Category","preferredDefinition":"Not expected or scheduled._A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time._Made less in size or amount or degree._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._Time during which some action is awaited; inactivity resulting in something being put off until a later time; the state of being slower or later._A grouping of items based on some commonality or by user defined characteristics.","longName":"6571013v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Neurologic toxicities","valueDescription":"Toxicity Neurologic","ValueMeaning":{"publicId":"6571107","version":"1","preferredName":"Toxicity Neurologic","longName":"6571107","preferredDefinition":"The finding of bodily harm due to the poisonous effects of something.: Pertaining to nerves or the nervous system.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Toxicity","conceptCode":"C27990","definition":"The finding of bodily harm due to the poisonous effects of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neurologic","conceptCode":"C25262","definition":"Pertaining to nerves or the nervous system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BC06AAD-2CD7-7AB7-E053-F662850A4730","latestVersionIndicator":"Yes","beginDate":"2018-11-28","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-28","modifiedBy":"ONEDATA","dateModified":"2018-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BC06AAD-2CF0-7AB7-E053-F662850A4730","beginDate":"2018-11-28","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-28","modifiedBy":"ONEDATA","dateModified":"2018-11-28","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"6424136","version":"1","preferredName":"Other","longName":"6424136","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"753441A1-068C-5A23-E053-F662850A6B7A","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-06","modifiedBy":"KUMMEROA","dateModified":"2023-02-02","changeDescription":null,"administrativeNotes":"2023.2.2 Alt VM added per ticket request CADSR0002006. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BBE9DB5-3729-75B1-E053-F662850AF381","beginDate":"2018-11-28","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-28","modifiedBy":"ONEDATA","dateModified":"2018-11-28","deletedIndicator":"No"},{"value":"Isotretinoin associated toxicities","valueDescription":"Toxicity Isotretinoin","ValueMeaning":{"publicId":"6571014","version":"1","preferredName":"Toxicity Isotretinoin","longName":"6571014","preferredDefinition":"The finding of bodily harm due to the poisonous effects of something.: A naturally-occurring retinoic acid with potential antineoplastic activity. Isotretinoin binds to and activates nuclear retinoic acid receptors (RARs); activated RARs serve as transcription factors that promote cell differentiation and apoptosis. This agent also exhibits immunomodulatory and anti-inflammatory responses and inhibits ornithine decarboxylase, thereby decreasing polyamine synthesis and keratinization.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Toxicity","conceptCode":"C27990","definition":"The finding of bodily harm due to the poisonous effects of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Isotretinoin","conceptCode":"C603","definition":"A naturally-occurring retinoic acid with potential antineoplastic activity. Isotretinoin binds to and activates nuclear retinoic acid receptors (RARs); activated RARs serve as transcription factors that promote cell differentiation and apoptosis. This agent also exhibits immunomodulatory and anti-inflammatory responses and inhibits ornithine decarboxylase, thereby decreasing polyamine synthesis and keratinization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BBE9DB5-3736-75B1-E053-F662850AF381","latestVersionIndicator":"Yes","beginDate":"2018-11-28","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-28","modifiedBy":"ONEDATA","dateModified":"2018-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BBE9DB5-374F-75B1-E053-F662850AF381","beginDate":"2018-11-28","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-28","modifiedBy":"ONEDATA","dateModified":"2018-11-28","deletedIndicator":"No"},{"value":"Renal side effects","valueDescription":"Renal side effects","ValueMeaning":{"publicId":"6571015","version":"1","preferredName":"Renal side effects","longName":"6571015","preferredDefinition":"Renal side effects","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BBE9DB5-3759-75B1-E053-F662850AF381","latestVersionIndicator":"Yes","beginDate":"2018-11-28","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-28","modifiedBy":"ONEDATA","dateModified":"2018-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BBE9DB5-3772-75B1-E053-F662850AF381","beginDate":"2018-11-28","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-28","modifiedBy":"ONEDATA","dateModified":"2018-11-28","deletedIndicator":"No"},{"value":"Infection","valueDescription":"Infection","ValueMeaning":{"publicId":"2561846","version":"1","preferredName":"Infection","longName":"2561846","preferredDefinition":"general term for invasion and growth of microorganisms in bodily tissues.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infection","conceptCode":"C0021311","definition":"general term for invasion and growth of microorganisms in bodily tissues.","evsSource":"UMLS_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-BEA3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-07-15","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-15","modifiedBy":"REEVESD","dateModified":"2012-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BBE9DB5-377E-75B1-E053-F662850AF381","beginDate":"2018-11-28","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-28","modifiedBy":"ONEDATA","dateModified":"2018-11-28","deletedIndicator":"No"},{"value":"Allergic reactions","valueDescription":"ALLERGIC REACTION","ValueMeaning":{"publicId":"2562549","version":"1","preferredName":"ALLERGIC REACTION","longName":"2562549","preferredDefinition":"ALLERGIC REACTION","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Allergic Reaction","conceptCode":"C0085600","definition":"Definition not available.","evsSource":"UMLS_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C162-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-04","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-10-04","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BBE9DB5-3792-75B1-E053-F662850AF381","beginDate":"2018-11-28","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-28","modifiedBy":"ONEDATA","dateModified":"2018-11-28","deletedIndicator":"No"},{"value":"Typhilitis","valueDescription":"Typhilitis","ValueMeaning":{"publicId":"6571016","version":"1","preferredName":"Typhilitis","longName":"6571016","preferredDefinition":"Typhilitis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BBE9DB5-379C-75B1-E053-F662850AF381","latestVersionIndicator":"Yes","beginDate":"2018-11-28","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-28","modifiedBy":"ONEDATA","dateModified":"2018-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BBE9DB5-37B5-75B1-E053-F662850AF381","beginDate":"2018-11-28","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-28","modifiedBy":"ONEDATA","dateModified":"2018-11-28","deletedIndicator":"No"},{"value":"Diarrhea","valueDescription":"Diarrhea","ValueMeaning":{"publicId":"4395762","version":"1","preferredName":"Diarrhea","longName":"4395762","preferredDefinition":"Watery bowel movements.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diarrhea","conceptCode":"C2987","definition":"Watery bowel movements.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-D82F-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BBE9DB5-37BF-75B1-E053-F662850AF381","beginDate":"2018-11-28","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-28","modifiedBy":"ONEDATA","dateModified":"2018-11-28","deletedIndicator":"No"},{"value":"Mucositis","valueDescription":"Mucositis","ValueMeaning":{"publicId":"2751408","version":"1","preferredName":"Mucositis","longName":"2751408","preferredDefinition":"A complication of some cancer therapies in which the lining of the digestive system becomes inflamed. Often seen as sores in the mouth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastrointestinal Mucositis","conceptCode":"C3853","definition":"Inflammation of the mucous membranes lining the gastrointestinal tract.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-0BA2-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BBE9DB5-37C9-75B1-E053-F662850AF381","beginDate":"2018-11-28","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-28","modifiedBy":"ONEDATA","dateModified":"2018-11-28","deletedIndicator":"No"},{"value":"Elevated ALT","valueDescription":"Elevated ALT","ValueMeaning":{"publicId":"6571017","version":"1","preferredName":"Elevated ALT","longName":"6571017","preferredDefinition":"Elevated ALT","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BBE9DB5-37D3-75B1-E053-F662850AF381","latestVersionIndicator":"Yes","beginDate":"2018-11-28","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-28","modifiedBy":"ONEDATA","dateModified":"2018-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BBE9DB5-37EC-75B1-E053-F662850AF381","beginDate":"2018-11-28","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-28","modifiedBy":"ONEDATA","dateModified":"2018-11-28","deletedIndicator":"No"},{"value":"Hyperbilirubinemia","valueDescription":"Hyperbilirubinemia","ValueMeaning":{"publicId":"4395655","version":"1","preferredName":"Hyperbilirubinemia","longName":"4395655","preferredDefinition":"Abnormally high level of bilirubin in the blood. Excess bilirubin is associated with jaundice.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyperbilirubinemia","conceptCode":"C27088","definition":"Abnormally high level of bilirubin in the blood. Excess bilirubin is associated with jaundice.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB79BBE-6C13-5F7C-E040-BB89AD435DD5","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BBE9DB5-37F6-75B1-E053-F662850AF381","beginDate":"2018-11-28","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-28","modifiedBy":"ONEDATA","dateModified":"2018-11-28","deletedIndicator":"No"},{"value":"Hypotension","valueDescription":"Hypotension","ValueMeaning":{"publicId":"4395785","version":"1","preferredName":"Hypotension","longName":"4395785","preferredDefinition":"Blood pressure that is abnormally low.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypotension","conceptCode":"C3128","definition":"Blood pressure that is abnormally low.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-DB36-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BBE9DB5-3800-75B1-E053-F662850AF381","beginDate":"2018-11-28","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-28","modifiedBy":"ONEDATA","dateModified":"2018-11-28","deletedIndicator":"No"},{"value":"Dysrhythmia","valueDescription":"Dysrhythmia","ValueMeaning":{"publicId":"2570266","version":"1","preferredName":"Dysrhythmia","longName":"2570266","preferredDefinition":"Dysrhythmia","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DF87-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BBE9DB5-380A-75B1-E053-F662850AF381","beginDate":"2018-11-28","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-28","modifiedBy":"ONEDATA","dateModified":"2018-11-28","deletedIndicator":"No"},{"value":"Cardiac toxicity","valueDescription":"Cardiac toxicity with decreased shortening fraction (SF) or ejection fraction (EF)","ValueMeaning":{"publicId":"6571018","version":"1","preferredName":"Cardiac toxicity with decreased shortening fraction (SF) or ejection fraction (EF)","longName":"6571018","preferredDefinition":"Cardiac toxicity with decreased shortening fraction (SF) or ejection fraction (EF)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BBE9DB5-3814-75B1-E053-F662850AF381","latestVersionIndicator":"Yes","beginDate":"2018-11-28","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-28","modifiedBy":"ONEDATA","dateModified":"2018-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BBE9DB5-382D-75B1-E053-F662850AF381","beginDate":"2018-11-28","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-28","modifiedBy":"ONEDATA","dateModified":"2018-11-28","deletedIndicator":"No"},{"value":"Renal toxicity","valueDescription":"Toxicity Renal","ValueMeaning":{"publicId":"6571019","version":"1","preferredName":"Toxicity Renal","longName":"6571019","preferredDefinition":"The finding of bodily harm due to the poisonous effects of something.: Of or pertaining to the kidney.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Toxicity","conceptCode":"C27990","definition":"The finding of bodily harm due to the poisonous effects of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Renal","conceptCode":"C25225","definition":"Of or pertaining to the kidney.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BBE9DB5-383A-75B1-E053-F662850AF381","latestVersionIndicator":"Yes","beginDate":"2018-11-28","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-28","modifiedBy":"ONEDATA","dateModified":"2018-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BBE9DB5-3853-75B1-E053-F662850AF381","beginDate":"2018-11-28","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-28","modifiedBy":"ONEDATA","dateModified":"2018-11-28","deletedIndicator":"No"},{"value":"Hematuria","valueDescription":"Hematuria","ValueMeaning":{"publicId":"2944888","version":"1","preferredName":"Hematuria","longName":"2944888","preferredDefinition":"A condition in which free hemoglobin is found in the urine. --2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematuria","conceptCode":"C3090","definition":"Blood in the urine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74464933-C61C-B990-E040-BB89AD4340F0","latestVersionIndicator":"Yes","beginDate":"2009-09-23","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BBE9DB5-385D-75B1-E053-F662850AF381","beginDate":"2018-11-28","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-28","modifiedBy":"ONEDATA","dateModified":"2018-11-28","deletedIndicator":"No"},{"value":"Hematologic toxicities","valueDescription":"Toxicity Hematologic","ValueMeaning":{"publicId":"6571020","version":"1","preferredName":"Toxicity Hematologic","longName":"6571020","preferredDefinition":"The finding of bodily harm due to the poisonous effects of something.: Pertaining to or related to the blood and blood-forming organs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Toxicity","conceptCode":"C27990","definition":"The finding of bodily harm due to the poisonous effects of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hematologic","conceptCode":"C62780","definition":"Pertaining to or related to the blood and blood-forming organs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BBE9DB5-386A-75B1-E053-F662850AF381","latestVersionIndicator":"Yes","beginDate":"2018-11-28","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-28","modifiedBy":"ONEDATA","dateModified":"2018-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BBE9DB5-3883-75B1-E053-F662850AF381","beginDate":"2018-11-28","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-28","modifiedBy":"ONEDATA","dateModified":"2018-11-28","deletedIndicator":"No"},{"value":"Dehydration","valueDescription":"Dehydration","ValueMeaning":{"publicId":"2946354","version":"1","preferredName":"Dehydration","longName":"2946354","preferredDefinition":"A condition resulting from the excessive loss of water from the body. It is usually caused by severe diarrhea, vomiting or diaphoresis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dehydration","conceptCode":"C26740","definition":"A condition resulting from the excessive loss of water from the body. It is usually caused by severe diarrhea, vomiting or diaphoresis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746D32D6-F8C8-1467-E040-BB89AD436E21","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AF10D789-0DEF-7D52-E053-4EBD850A3B91","beginDate":"2020-09-11","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-11","modifiedBy":"ONEDATA","dateModified":"2020-09-11","deletedIndicator":"No"},{"value":"TA-TMA","valueDescription":"Hematopoietic Cell Transplantation Associated Thrombotic Microangiopathy","ValueMeaning":{"publicId":"7415649","version":"1","preferredName":"Hematopoietic Cell Transplantation Associated Thrombotic Microangiopathy","longName":"7415649","preferredDefinition":"A therapeutic procedure that involves the transplantation of hematopoietic stem cells, either with the patient as their own donor or from a donor to a patient. This can be used for treatment of malignant and non-malignant diseases.: Joined in some kind of relationship.: The syndromes of microangiopathic hemolytic anemia, thrombocytopenia, and variable signs of organ impairment, due to platelet aggregation in the microcirculation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematopoietic Cell Transplantation","conceptCode":"C15431","definition":"A therapeutic procedure that involves the transplantation of hematopoietic stem cells, either with the patient as their own donor or from a donor to a patient. This can be used for treatment of malignant and non-malignant diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Associated","conceptCode":"C25281","definition":"Joined in some kind of relationship.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Thrombotic Microangiopathy","conceptCode":"C62605","definition":"A microvascular coagulopathy that may result from systemic vascular endothelial injury triggering the development of a procoagulant state, activation of the complement cascade, and microthrombi formation. Signs may include hemolytic anemia, thrombocytopenia, hypertension and renal dysfunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF10601F-B1EC-0B7B-E053-4EBD850A37CB","latestVersionIndicator":"Yes","beginDate":"2020-09-11","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-11","modifiedBy":"ONEDATA","dateModified":"2020-09-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AF10601F-B205-0B7B-E053-4EBD850A37CB","beginDate":"2020-09-11","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-11","modifiedBy":"ONEDATA","dateModified":"2020-09-11","deletedIndicator":"No"},{"value":"Elevated ALT, AST, GGT","valueDescription":"Alanine Aminotransferase Measurement Aspartate Aminotransferase Measurement Gamma Glutamyl Transpeptidase Measurement Elevated","ValueMeaning":{"publicId":"7415642","version":"1","preferredName":"Alanine Aminotransferase Measurement Aspartate Aminotransferase Measurement Gamma Glutamyl Transpeptidase Measurement Elevated","longName":"7415642","preferredDefinition":"A quantitative measurement of alanine aminotransferase present in a sample.: A quantitative measurement of aspartate aminotransferase present in a sample.: A quantitative measurement of the amount of gamma glutamyl transpeptidase present in a sample.: Raised or increased above normal levels or limits.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alanine Aminotransferase Measurement","conceptCode":"C64433","definition":"A quantitative measurement of alanine aminotransferase present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Aspartate Aminotransferase Measurement","conceptCode":"C64467","definition":"A quantitative measurement of aspartate aminotransferase present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Gamma Glutamyl Transpeptidase Measurement","conceptCode":"C64847","definition":"A quantitative measurement of the amount of gamma glutamyl transpeptidase present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Elevated","conceptCode":"C25493","definition":"Raised or increased above normal levels or limits.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF10D789-0DFE-7D52-E053-4EBD850A3B91","latestVersionIndicator":"Yes","beginDate":"2020-09-11","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-11","modifiedBy":"ONEDATA","dateModified":"2020-09-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AF10D789-0E17-7D52-E053-4EBD850A3B91","beginDate":"2020-09-11","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-11","modifiedBy":"ONEDATA","dateModified":"2020-09-11","deletedIndicator":"No"},{"value":"Sargramostim associated toxicities","valueDescription":"Associated Toxicity Sargramostim","ValueMeaning":{"publicId":"7415650","version":"1","preferredName":"Associated Toxicity Sargramostim","longName":"7415650","preferredDefinition":"Joined in some kind of relationship.: The finding of bodily harm due to the poisonous effects of something.: A recombinant therapeutic agent chemically identical to endogenous human GM-CSF except a leucine substitution in position 23.  Binding to specific cell surface receptors, sargramostim modulates the proliferation and differentiation of a variety of hematopoietic progenitor cells with some specificity towards stimulation of leukocyte production and may reverse treatment-induced neutropenias. This agent also promotes antigen presentation, up-regulates antibody-dependent cellular cytotoxicity (ADCC), and increases interleukin-2-mediated lymphokine-activated killer cell function; it may also augment host antitumoral immunity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Associated","conceptCode":"C25281","definition":"Joined in some kind of relationship.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Toxicity","conceptCode":"C27990","definition":"The finding of bodily harm due to the poisonous effects of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Sargramostim","conceptCode":"C1492","definition":"A recombinant therapeutic agent chemically identical to endogenous human GM-CSF except a leucine substitution in position 23.  Binding to specific cell surface receptors, sargramostim modulates the proliferation and differentiation of a variety of hematopoietic progenitor cells with some specificity towards stimulation of leukocyte production and may reverse treatment-induced neutropenias. This agent also promotes antigen presentation, up-regulates antibody-dependent cellular cytotoxicity (ADCC), and increases interleukin-2-mediated lymphokine-activated killer cell function; it may also augment host antitumoral immunity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF10601F-B213-0B7B-E053-4EBD850A37CB","latestVersionIndicator":"Yes","beginDate":"2020-09-11","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-11","modifiedBy":"ONEDATA","dateModified":"2020-09-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AF10601F-B22C-0B7B-E053-4EBD850A37CB","beginDate":"2020-09-11","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-11","modifiedBy":"ONEDATA","dateModified":"2020-09-11","deletedIndicator":"No"},{"value":"Other dinutuximab associated toxicities","valueDescription":"Toxicity Associated Dinutuximab","ValueMeaning":{"publicId":"7415651","version":"1","preferredName":"Toxicity Associated Dinutuximab","longName":"7415651","preferredDefinition":"The finding of bodily harm due to the poisonous effects of something.: Joined in some kind of relationship.: A chimeric mouse/human monoclonal antibody with potential antineoplastic activity. Dinutuximab binds to the ganglioside GD2 and induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity against GD2-expressing tumor cells.  GD2 is overexpressed in malignant melanoma, neuroblastoma, osteosarcoma, and small cell carcinoma of the lung.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Toxicity","conceptCode":"C27990","definition":"The finding of bodily harm due to the poisonous effects of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Associated","conceptCode":"C25281","definition":"Joined in some kind of relationship.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dinutuximab","conceptCode":"C1570","definition":"A chimeric mouse/human monoclonal antibody with potential antineoplastic activity. Dinutuximab binds to the ganglioside GD2 and induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity against GD2-expressing tumor cells.  GD2 is overexpressed in malignant melanoma, neuroblastoma, osteosarcoma, and small cell carcinoma of the lung.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF10601F-B23A-0B7B-E053-4EBD850A37CB","latestVersionIndicator":"Yes","beginDate":"2020-09-11","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-11","modifiedBy":"ONEDATA","dateModified":"2020-09-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AF10601F-B253-0B7B-E053-4EBD850A37CB","beginDate":"2020-09-11","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-11","modifiedBy":"ONEDATA","dateModified":"2020-09-11","deletedIndicator":"No"},{"value":"Visual changes","valueDescription":"Visual Change","ValueMeaning":{"publicId":"7113104","version":"1","preferredName":"Visual Change","longName":"7113104","preferredDefinition":"An alteration in the visual system of an individual.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Visual Change","conceptCode":"C157424","definition":"An alteration in the visual system of an individual.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9A79AD4B-7E0D-5B91-E053-F662850AC723","latestVersionIndicator":"Yes","beginDate":"2019-12-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-24","modifiedBy":"ONEDATA","dateModified":"2019-12-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AF10601F-B267-0B7B-E053-4EBD850A37CB","beginDate":"2020-09-11","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-11","modifiedBy":"ONEDATA","dateModified":"2020-09-11","deletedIndicator":"No"},{"value":"Pain","valueDescription":"Pain","ValueMeaning":{"publicId":"2946005","version":"1","preferredName":"Pain","longName":"2946005","preferredDefinition":"The sensation of discomfort, distress, or agony, resulting from the stimulation of specialized nerve endings.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pain","conceptCode":"C3303","definition":"The sensation of discomfort, distress, or agony, resulting from the stimulation of specialized nerve endings.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746944AF-4239-DCDB-E040-BB89AD437B02","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AF10601F-B271-0B7B-E053-4EBD850A37CB","beginDate":"2020-09-11","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-11","modifiedBy":"ONEDATA","dateModified":"2020-09-11","deletedIndicator":"No"},{"value":"Hyponatremia","valueDescription":"Hyponatremia","ValueMeaning":{"publicId":"4291753","version":"1","preferredName":"Hyponatremia","longName":"4291753","preferredDefinition":"Lower than normal levels of sodium in the circulating blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyponatremia","conceptCode":"C37976","definition":"Lower than normal levels of sodium in the circulating blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-6341-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AF10601F-B27B-0B7B-E053-4EBD850A37CB","beginDate":"2020-09-11","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-11","modifiedBy":"ONEDATA","dateModified":"2020-09-11","deletedIndicator":"No"},{"value":"Nausea and vomiting toxicities","valueDescription":"Vomiting Nausea","ValueMeaning":{"publicId":"7415652","version":"1","preferredName":"Vomiting Nausea","longName":"7415652","preferredDefinition":"Forceful ejection of the contents of the stomach through the mouth.: Upper abdominal discomfort associated with an urge to vomit.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vomiting","conceptCode":"C3442","definition":"Forceful ejection of the contents of the stomach through the mouth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Nausea","conceptCode":"C3258","definition":"Upper abdominal discomfort associated with an urge to vomit.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AF10601F-B288-0B7B-E053-4EBD850A37CB","latestVersionIndicator":"Yes","beginDate":"2020-09-11","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-11","modifiedBy":"ONEDATA","dateModified":"2020-09-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AF10601F-B2A1-0B7B-E053-4EBD850A37CB","beginDate":"2020-09-11","endDate":null,"createdBy":"STARGELM","dateCreated":"2020-09-11","modifiedBy":"ONEDATA","dateModified":"2020-09-11","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6571012","version":"1","preferredName":"Unplanned Dose Reduced Or Therapeutic Procedure Delay Category","preferredDefinition":"Not expected or scheduled.:A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.:Made less in size or amount or degree.:An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.:An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.:Time during which some action is awaited; inactivity resulting in something being put off until a later time; the state of being slower or later.:A grouping of items based on some commonality or by user defined characteristics.","longName":"6571012v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unplanned","conceptCode":"C151899","definition":"Not expected or scheduled.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"Dose","conceptCode":"C25488","definition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Reduced","conceptCode":"C25640","definition":"Made less in size or amount or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Delay","conceptCode":"C25476","definition":"Time during which some action is awaited; inactivity resulting in something being put off until a later time; the state of being slower or later.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BBE9DB5-3702-75B1-E053-F662850AF381","latestVersionIndicator":"Yes","beginDate":"2018-11-28","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-28","modifiedBy":"ONEDATA","dateModified":"2018-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BBE9DB5-3713-75B1-E053-F662850AF381","latestVersionIndicator":"Yes","beginDate":"2018-11-28","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-28","modifiedBy":"STARGELM","dateModified":"2020-09-11","changeDescription":"Curated for ANBL17P1","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[{"name":"COG","type":"USED_BY","context":"COG"}],"ReferenceDocuments":[{"name":"Provide details of unplanned","type":"Preferred Question Text","description":"Provide details of unplanned dose reductions or treatment delays during this reporting period:","url":null,"context":"COG"},{"name":"COG CRF Text 01","type":"Alternate Question Text","description":"Provide details of dose reductions or treatment delays during this reporting period:","url":null,"context":"COG"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Provide details of unplanned Lorlatinib dose reduction or treatment held during this reporting period:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BBEB094-EE26-113C-E053-F662850AC482","latestVersionIndicator":"Yes","beginDate":"2018-11-28","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2018-11-28","modifiedBy":"LAMEMIL","dateModified":"2021-11-17","changeDescription":"Curated for ANBL17P1","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}